MedWatch

Experiences from Covid-19 will create success for Demant's virtual product launch

It's unfortunate for hearing aid company Demant that the launch of the firm's new flagship manufacturer coincides with the greatest crisis in the history of the industry. But experiences based on the last nine months in Covid-19 alertness cause CEO Søren Nielsen to trust in a successful launch.

Photo: Niels Hougaard/ERH

Since March, when the Covid-19 crisis started, hearing firm Demant has undergone a significant transitional process, where almost all work procedures in the C25 company have been subjected to a 'new normal' with virtual work processes becoming standard rather than physical meetings and face-to-face interactions.

Demant's recent transition leads the President and CEO Søren Nielsen to strongly believe that the firm's new flagship product, the hearing aid Oticon More, will be successful. It replaces its predecessor, the blockbuster Oticon Opn S.

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

Related articles